“The Central Govt will be spending over Rs.3,000 crore in the next three years (under the XII Plan) towards enhancing the capacity of the regulators both at the Centre and State levels. While the no. of regulators would be increased to 1,000 from 500 at the Central level, as many as 3,000 regulators would be deployed at the state levels. The govt would set up state-of-the-art testing labs at ports to ensure that the pharmaceuticals and drugs exports shipments met global quality standards. The govt was following a “zero tolerance” policy for ensuring that India not only maintained but further strengthened its ranking in the world pharmaceuticals market. Measures on quality assurance were even more important when a big opportunity would be unfolding in the off-patent generics in the next few years.” -Drugs Controller General (India) G. N. Singh